Sana Biotechnology, Inc. (SANA) Tops Q2 EPS by 2c

Sana Biotechnology, Inc. (NASDAQ: SANA) reported Q2 EPS of ($0.13), $0.02 better than the analyst estimate of ($0.15).

For earnings history and earnings-related data on Sana Biotechnology, Inc. (SANA) click here.

You May Also Be Interested In

• OpenAI: after the Hugging Face incident, we committed to conducting a much broader review of actions taken by our models
• Bending Spoons closes $1.25B term loan add-on to fund Miro deal
• Boeing and Bell Boeing receive defense contracts totaling $56.4M